Idiopathic inflammatory myopathies : nature.com subject feedshttps://www.nature.com/subjects/idiopathic-inflammatory-myopathies.atom2024-03-29T06:39:27+00:00Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroupshttps://www.nature.com/articles/s41584-024-01106-82024-03-21T00:00:00+00:002024-03-21T00:00:00+00:00Thomas Khoo et al.Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progresshttps://www.nature.com/articles/s41584-023-01054-92023-12-06T00:00:00+00:002023-12-06T00:00:00+00:00Xin Lu et al.International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiativehttps://www.nature.com/articles/s41584-023-01045-w2023-11-09T00:00:00+00:002023-11-09T00:00:00+00:00Alexander G. S. Oldroyd et al.YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathieshttps://www.nature.com/articles/s41598-023-46491-42023-11-06T00:00:00+00:002023-11-06T00:00:00+00:00Mónica Vázquez-Del Mercado et al.Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japanhttps://www.nature.com/articles/s41598-023-44092-92023-10-11T00:00:00+00:002023-10-11T00:00:00+00:00Qingqing Hu et al.Epidemiology of the idiopathic inflammatory myopathieshttps://www.nature.com/articles/s41584-023-01033-02023-10-06T00:00:00+00:002023-10-06T00:00:00+00:00Thomas Khoo et al.Insights into juvenile myositis via engineered musclehttps://www.nature.com/articles/s41584-023-01003-62023-07-26T00:00:00+00:002023-07-26T00:00:00+00:00Hanna KimJuvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical carehttps://www.nature.com/articles/s41584-023-00967-92023-05-15T00:00:00+00:002023-05-15T00:00:00+00:00Charalampia Papadopoulou et al.Co-trimoxazole reduces mortality in anti-MDA5-DMhttps://www.nature.com/articles/s41584-023-00939-z2023-03-10T00:00:00+00:002023-03-10T00:00:00+00:00Robert PhillipsMapping the immune landscape of MDA5+ dermatomyositishttps://www.nature.com/articles/s41584-022-00879-02022-11-18T00:00:00+00:002022-11-18T00:00:00+00:00Jessica McHughThe SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositishttps://www.nature.com/articles/s41598-022-09943-x2022-04-07T00:00:00+00:002022-04-07T00:00:00+00:00Yufei Zhao et al.Targeting necroptosis for the treatment of myositishttps://www.nature.com/articles/s41584-022-00775-72022-04-06T00:00:00+00:002022-04-06T00:00:00+00:00Kanneboyina Nagaraju et al.Idiopathic inflammatory myopathieshttps://www.nature.com/articles/s41572-021-00321-x2021-12-02T00:00:00+00:002021-12-02T00:00:00+00:00Ingrid E. Lundberg et al.Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndromehttps://www.nature.com/articles/s41598-021-01992-y2021-11-19T00:00:00+00:002021-11-19T00:00:00+00:00Sara Remuzgo-Martínez et al.Profiling comorbidities of inclusion body myositishttps://www.nature.com/articles/s41584-021-00703-12021-09-28T00:00:00+00:002021-09-28T00:00:00+00:00Sarah OnuoraA novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositishttps://www.nature.com/articles/s41598-021-96292-w2021-08-23T00:00:00+00:002021-08-23T00:00:00+00:00Wenwen Xu et al.Texture analysis of muscle MRI: machine learning-based classifications in idiopathic inflammatory myopathieshttps://www.nature.com/articles/s41598-021-89311-32021-05-10T00:00:00+00:002021-05-10T00:00:00+00:00Keita Nagawa et al.Slicing and dicing myositis for cures and preventionhttps://www.nature.com/articles/s41584-021-00592-42021-03-11T00:00:00+00:002021-03-11T00:00:00+00:00Frederick W. MillerImmune-mediated necrotizing myopathy: clinical features and pathogenesishttps://www.nature.com/articles/s41584-020-00515-92020-10-22T00:00:00+00:002020-10-22T00:00:00+00:00Yves Allenbach et al.Autoantibodies disrupt muscle repair and promote IIM progressionhttps://www.nature.com/articles/s41584-020-0488-z2020-07-31T00:00:00+00:002020-07-31T00:00:00+00:00Sarah OnuoraGene expression profiles in muscle differ in myositis subtypeshttps://www.nature.com/articles/s41584-020-0468-32020-07-07T00:00:00+00:002020-07-07T00:00:00+00:00Sarah OnuoraCan machine learning unravel the complex IIM spectrum?https://www.nature.com/articles/s41584-020-0412-62020-03-27T00:00:00+00:002020-03-27T00:00:00+00:00James B. Lilleker et al.Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitorshttps://www.nature.com/articles/s41467-020-14734-x2020-02-14T00:00:00+00:002020-02-14T00:00:00+00:00Yuki Saito et al.NET formation implicated in myositishttps://www.nature.com/articles/s41584-020-0389-12020-02-12T00:00:00+00:002020-02-12T00:00:00+00:00Jessica McHughCombined immunosuppression for ILD in myositishttps://www.nature.com/articles/s41584-019-0328-12019-10-15T00:00:00+00:002019-10-15T00:00:00+00:00Joanna CollisonNew insights into myositis geneticshttps://www.nature.com/articles/s41584-019-0258-y2019-06-18T00:00:00+00:002019-06-18T00:00:00+00:00Sarah OnuoraAmyloid-PET: a new tool for diagnosing IBM?https://www.nature.com/articles/s41584-019-0223-92019-05-02T00:00:00+00:002019-05-02T00:00:00+00:00Iago Pinal-Fernandez et al.Serum biomarkers of disease activity in JDMhttps://www.nature.com/articles/s41584-019-0210-12019-03-26T00:00:00+00:002019-03-26T00:00:00+00:00Joanna CollisonInclusion body myositis: clinical features and pathogenesishttps://www.nature.com/articles/s41584-019-0186-x2019-03-05T00:00:00+00:002019-03-05T00:00:00+00:00Steven A. GreenbergCancer risk associated with anti-TIF1 antibodieshttps://www.nature.com/articles/s41584-019-0164-32019-01-07T00:00:00+00:002019-01-07T00:00:00+00:00Joanna Collison